Serum Institute Awaiting Gavi Push For $2 Pneumococcal Vaccine
Pricing Comes Close To MSF’s $5 A Course Target
Serum Institute hopes to hear by May from Gavi on whether it will consider the firm's $2 per dose pneumococcal conjugate vaccine for immunization programs across developing countries. Its 10-valent vaccine, versus GSK’s 11-valent and Pfizer’s 13-valent vaccines, is 30% cheaper.
